期刊文献+

临床输血对肿瘤患者治疗的效果探讨 被引量:3

Effect of clinical transfusion on treatment of tumor patients
原文传递
导出
摘要 目的探讨输血在肿瘤患者临床治疗过程中所发挥的效果。方法随机选取100例临床肿瘤患者,分为两组,分别为:实验组(给予一般治疗加输血治疗)和对照组(给予一般治疗),治疗后检测血红蛋白(Hb),计算其恢复率,给予疗效评价。结果实验组患者经输血治疗后有效为42例(84%),对照组经过一般治疗后,有效为28例(56%);经统计学分析,实验组患者输血治疗后在整个治疗肿瘤过程中效果明显优于对照组(P<0.05),具有统计学意义。结论肿瘤患者给予正确输血治疗后可以有效提高患者的Hb恢复率,提高了患者的临床治疗效果,延长患者的生存时间。 Objective To explore the effect of blood transfusion in the treatment of patients with malignant tumor.Methods Totally 100 patients with tumor were randomly selected and divided into two groups: the experimental group( general treatment plus blood transfusion) and the control group( general treatment). After the treatment,the Hb was detected,and the recovery rate was calculated and the curative effect was evaluated. Results Totally 42 cases( 84%)were effective after blood transfusion in the experimental group,and 28 cases( 56%) were effective after general treatment in the control group. The experimental group were significantly better than the control group in the whole treatment process after blood transfusion treatment( P〈 0. 05),with statistical significance. Conclusion After the right blood transfusion treatment,the tumor patients can effectively improve the recovery rate of Hb,improve the clinical treatment effect and prolong the survival time.
作者 杨福娟 方晓霞 张会敏 朱智龄 YANG Fu-juan;FANG Xiao-xia;ZHANG Hui-rain;ZHU Zhi-ling(Xinxiang Central Hospital,Xinxiang,Henan 453000,China)
出处 《医药论坛杂志》 2018年第7期11-13,共3页 Journal of Medical Forum
基金 河南省教育厅人文社会科学研究项目(2017-ZZJH-439)
关键词 肿瘤患者 输血治疗 血红蛋白 Tumor patients Blood transfusion treatment Hb
  • 相关文献

参考文献6

二级参考文献81

  • 1王青梅,刘景汉,王海军.白血病ABO血型抗原改变的2例报告[J].临床输血与检验,2000,2(1):58-59. 被引量:18
  • 2苏智雄,黎乐群,肖开银,尚丽明,叶新平,覃忠.围手术期输血对原发性肝癌患者免疫抑制酸性蛋白的影响[J].中国输血杂志,2006,19(3):209-210. 被引量:9
  • 3袁举,马建新.河南省人民医院2003~2005年输血不良反应的调查[J].中国误诊学杂志,2007,7(10):2423-2423. 被引量:25
  • 4Lange MM, van Hilten JA, van de Watering LM, et al . Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br J Surg, 2009 ; 96 (7) :734 - 740.
  • 5Grogan M,Thomas GM, Melamed I, et al. The important hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer, 1999; 86(8) : 1528 - 1536.
  • 6Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer, 2001; 91(4): 771 -778.
  • 7Konopke R, Kersting S, Bunk A, et al . Colorectal liver metastasis surgery : analysis of risk factors predicting postoperative complications in relation to the extent of resection. Int J Colorectal Dis, 2009 ; 24 (6) : 687 - 697.
  • 8Claas FH, Roelen DL, van Rood JJ, et al. Modulation of the alloimmune response by blood transfusions. Transfus Clin Biol, 2001; 8 (3) :315 -317.
  • 9Silliman CC. The epidemiology and clinical manifestations of TRALL. Transfusion Alternatives in Transfusion Medicine,2004,6(suppl) :46 - 47.
  • 10Garcia Suarez J, Krsnik I, Reyes E, et al. Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rate of infection and outcome to yanger adults:a prospective study of risk-adapted therapy. BrJ Haematol, 2003 ; 120 ( 2 ) : 209 - 216.

共引文献50

同被引文献17

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部